Genscript Biotech Corporation Asset Resilience Ratio

Latest as of December 2025: 13.79%

Genscript Biotech Corporation asset resilience ratio. Genscript Biotech Corporation (G51) has an Asset Resilience Ratio of 13.79% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Genscript Biotech Corporation (G51) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€669.50 Million

≈ $782.72 Million USD Cash + Short-term Investments

Total Assets

€4.85 Billion

≈ $5.67 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio of Genscript Biotech Corporation (2017–2025)

Asset resilience ratio of Genscript Biotech Corporation from 2017 to 2025. This chart shows how Genscript Biotech Corporation's Asset Resilience Ratio has changed over time. Read G51 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Genscript Biotech Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Genscript Biotech Corporation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€669.50 Million	13.79%
Total Liquid Assets	€669.50 Million	13.79%

Asset Resilience Insights

Moderate Liquidity: Genscript Biotech Corporation has 13.79% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Genscript Biotech Corporation Industry Peers by Asset Resilience Ratio

Compare Genscript Biotech Corporation's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

Genscript Biotech Corporation Asset Resilience Ratio by Year (2017–2025)

Genscript Biotech Corporation asset resilience ratio by year from 2017 to 2025. The table below shows the annual Asset Resilience Ratio data for Genscript Biotech Corporation.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	13.79%	€669.50 Million ≈ $782.72 Million	€4.85 Billion ≈ $5.67 Billion	+4.53pp
2024-12-31	9.27%	€489.19 Million ≈ $571.92 Million	€5.28 Billion ≈ $6.17 Billion	-4.95pp
2023-12-31	14.22%	€481.65 Million ≈ $563.10 Million	€3.39 Billion ≈ $3.96 Billion	-3.03pp
2022-12-31	17.25%	€439.33 Million ≈ $513.62 Million	€2.55 Billion ≈ $2.98 Billion	+7.30pp
2021-12-31	9.95%	€222.23 Million ≈ $259.81 Million	€2.23 Billion ≈ $2.61 Billion	+0.13pp
2020-12-31	9.82%	€142.11 Million ≈ $166.14 Million	€1.45 Billion ≈ $1.69 Billion	-9.76pp
2019-12-31	19.58%	€174.13 Million ≈ $203.57 Million	€889.41 Million ≈ $1.04 Billion	+11.94pp
2018-12-31	7.64%	€70.06 Million ≈ $81.90 Million	€916.98 Million ≈ $1.07 Billion	+7.03pp
2017-12-31	0.61%	€3.09 Million ≈ $3.61 Million	€504.26 Million ≈ $589.54 Million	--

pp = percentage points

About Genscript Biotech Corporation

F:G51 Germany Biotechnology

Market Cap

$10.11 Billion

€8.65 Billion EUR

Market Cap Rank

#4429 Global

#776 in Germany

Share Price

€3.96

Change (1 day)

-7.04%

52-Week Range

€1.14 - €5.45

All Time High

€5.45